Lizet E. van der Kolk

6.4k total citations
33 papers, 1.3k citations indexed

About

Lizet E. van der Kolk is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Lizet E. van der Kolk has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 9 papers in Pathology and Forensic Medicine and 7 papers in Molecular Biology. Recurrent topics in Lizet E. van der Kolk's work include BRCA gene mutations in cancer (16 papers), Cancer Genomics and Diagnostics (6 papers) and Genetic factors in colorectal cancer (5 papers). Lizet E. van der Kolk is often cited by papers focused on BRCA gene mutations in cancer (16 papers), Cancer Genomics and Diagnostics (6 papers) and Genetic factors in colorectal cancer (5 papers). Lizet E. van der Kolk collaborates with scholars based in Netherlands, United States and Taiwan. Lizet E. van der Kolk's co-authors include Joke W. Baars, Marinus H. J. van Oers, Martin H. Prins, A.J. Grillo-López, C. Erik Hack, Frans B.L. Hogervorst, Eveline M. A. Bleiker, Petra M. Nederlof, Lennart Mulder and Jelle Wesseling and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Lizet E. van der Kolk

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lizet E. van der Kolk Netherlands 17 359 337 322 308 267 33 1.3k
K Michalová Czechia 26 262 0.7× 211 0.6× 217 0.7× 844 2.7× 159 0.6× 171 2.1k
Arto Leminen Finland 28 206 0.6× 264 0.8× 538 1.7× 415 1.3× 120 0.4× 60 1.9k
Pamela J. Paley United States 26 341 0.9× 216 0.6× 392 1.2× 466 1.5× 144 0.5× 41 2.2k
Manoj Raghavan United Kingdom 17 252 0.7× 157 0.5× 257 0.8× 734 2.4× 259 1.0× 45 1.7k
Seon‐Hee Yim South Korea 20 282 0.8× 109 0.3× 288 0.9× 457 1.5× 83 0.3× 41 1.2k
Pooja Hingorani United States 24 185 0.5× 159 0.5× 725 2.3× 577 1.9× 307 1.1× 72 1.8k
Marlena Kern United States 14 384 1.1× 100 0.3× 156 0.5× 320 1.0× 613 2.3× 21 1.5k
Blanca Sánchez‐González Spain 20 72 0.2× 381 1.1× 304 0.9× 721 2.3× 144 0.5× 70 1.5k
Johanna G. H. van Nes Netherlands 16 122 0.3× 160 0.5× 681 2.1× 288 0.9× 314 1.2× 31 1.2k
Jurgen M.J. Piek Netherlands 18 311 0.9× 124 0.4× 269 0.8× 286 0.9× 99 0.4× 93 1.6k

Countries citing papers authored by Lizet E. van der Kolk

Since Specialization
Citations

This map shows the geographic impact of Lizet E. van der Kolk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizet E. van der Kolk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizet E. van der Kolk more than expected).

Fields of papers citing papers by Lizet E. van der Kolk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizet E. van der Kolk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizet E. van der Kolk. The network helps show where Lizet E. van der Kolk may publish in the future.

Co-authorship network of co-authors of Lizet E. van der Kolk

This figure shows the co-authorship network connecting the top 25 collaborators of Lizet E. van der Kolk. A scholar is included among the top collaborators of Lizet E. van der Kolk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizet E. van der Kolk. Lizet E. van der Kolk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ausems, Margreet G.E.M., Inge M. van Oort, C. Marleen Kets, et al.. (2024). Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives. Familial Cancer. 23(2). 165–175.
2.
3.
Menko, Fred H., Kim Monkhorst, Frans B.L. Hogervorst, et al.. (2022). Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation. Critical Reviews in Oncology/Hematology. 176. 103642–103642. 6 indexed citations
4.
Samsom, Kris G., Linda J.W. Bosch, Luuk J. Schipper, et al.. (2020). Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE). BMC Medical Genomics. 13(1). 169–169. 24 indexed citations
5.
Kuijk, Sander M. J. van, Cora M. Aalfs, Christi J. van Asperen, et al.. (2020). Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making. Journal of Community Genetics. 12(1). 101–110. 9 indexed citations
6.
Dieren, Jolanda M. van, Liudmila L. Kodach, Lizet E. van der Kolk, et al.. (2020). Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers. Endoscopy. 52(10). 839–846. 24 indexed citations
7.
Menko, Fred H., et al.. (2020). The uptake of predictive DNA testing in 40 families with a pathogenic BRCA1/BRCA2 variant. An evaluation of the proband-mediated procedure. European Journal of Human Genetics. 28(8). 1020–1027. 20 indexed citations
8.
Beek, Irma van de, Ellen M.A. Smets, Joanne A. de Hullu, et al.. (2019). Genetic counseling of patients with ovarian carcinoma: acceptance, timing, and psychological wellbeing. Journal of Community Genetics. 11(2). 183–191. 3 indexed citations
9.
Medendorp, Niki M., Marij A. Hillen, Cora M. Aalfs, et al.. (2019). ‘We don’t know for sure’: discussion of uncertainty concerning multigene panel testing during initial cancer genetic consultations. Familial Cancer. 19(1). 65–76. 10 indexed citations
10.
Kuijk, Sander M. J. van, Cora M. Aalfs, Christi J. van Asperen, et al.. (2018). The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study. Familial Cancer. 18(1). 137–146. 18 indexed citations
11.
Kaaij, Rosa T. van der, Jolanda M. van Dieren, Pétur Snæbjörnsson, et al.. (2018). Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer. British journal of surgery. 105(2). e176–e182. 36 indexed citations
12.
Kuijk, Sander M. J. van, Cora M. Aalfs, Christi J. van Asperen, et al.. (2018). Online decision support for persons having a genetic predisposition to cancer and their partners during reproductive decision‐making. Journal of Genetic Counseling. 28(3). 533–542. 15 indexed citations
13.
Post, Rachel S. van der, Jolanda van Dieren, Nicoline Hoogerbrugge, et al.. (2017). Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria. Gastrointestinal Endoscopy. 87(2). 397–404.e2. 19 indexed citations
14.
15.
Lips, Esther H., Lennart Mulder, Gabe S. Sonke, et al.. (2016). BRCA1 -Mutated Estrogen Receptor–Positive Breast Cancer Shows BRCAness, Suggesting Sensitivity to Drugs Targeting Homologous Recombination Deficiency. Clinical Cancer Research. 23(5). 1236–1241. 15 indexed citations
16.
Tilborg, Theodora C van, I. A. P. Derks-Smeets, Jan C. Oosterwijk, et al.. (2016). Serum AMH levels in healthy women fromBRCA1/2mutated families: are they reduced?. Human Reproduction. 31(11). 2651–2659. 35 indexed citations
17.
Post, Rachel S. van der, Ingrid P. Vogelaar, Peggy Manders, et al.. (2015). Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1. Gastroenterology. 149(4). 897–906.e19. 67 indexed citations
18.
Bleiker, Eveline M. A., Margreet G.E.M. Ausems, Lizet E. van der Kolk, et al.. (2014). Routine assessment of psychosocial problems after cancer genetic counseling: results from a randomized controlled trial. Clinical Genetics. 87(5). 419–427. 10 indexed citations
19.
Kolk, Lizet E. van der, A.J. Grillo-López, Joke W. Baars, & Marinus H. J. van Oers. (2003). Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy. Leukemia. 17(8). 1658–1664. 52 indexed citations
20.
Kolk, Lizet E. van der, et al.. (2002). [An epidemic of epileptic seizures after consumption of herbal tea].. PubMed. 146(17). 813–6. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Michalová Breakdown of academic impact, for papers by Arto Leminen Breakdown of academic impact, for papers by Pamela J. Paley Breakdown of academic impact, for papers by Manoj Raghavan Breakdown of academic impact, for papers by Seon‐Hee Yim Breakdown of academic impact, for papers by Pooja Hingorani Breakdown of academic impact, for papers by Marlena Kern Breakdown of academic impact, for papers by Blanca Sánchez‐González Breakdown of academic impact, for papers by Johanna G. H. van Nes Breakdown of academic impact, for papers by Jurgen M.J. Piek
Rankless by CCL
2026